Search results
Colossal is more than just a genetics and biosciences company. Founded by Ben Lamm and world-renowned geneticist and serial biotech founder George Church. Colossal is led by CEO Ben Lamm and anchored by some of the most recognized names in science and industry.
Colossal Biosciences Inc. is an American biotechnology and genetic engineering company working to de-extinct the woolly mammoth, the Tasmanian tiger, and the dodo. In 2023, it stated that it wants to have woolly mammoth hybrid calves by 2028, and wants to reintroduce them to the Arctic tundra habitat.
Colossal’s landmark de-extinction project will be the resurrection of the Woolly Mammoth - or more specifically a cold-resistant elephant with all of the core biological traits of the Woolly Mammoth.
Through technological and engineering breakthroughs in biosciences and genetics, Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition.
Jan 31, 2023 · Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States Inn.
Jul 11, 2024 · Colossal Biosciences did not provide funding or support for the research. And 3-D genomic data will also be useful in efforts to save existing organisms from extinction. “Given the climate ...
Currently, a company called Colossal Biosciences are leading the drive to bring the woolly mammoth back to life. Their strategy is to take an Asian elephant genome and introduce a large number of ...
Jul 11, 2024 · The approach in the paper could also help researchers to assemble a complete mammoth genome, says Eriona Hysolli, head of biological sciences at Colossal Biosciences, a biotechnology firm in ...
Mar 6, 2024 · The breakthrough — announced today by the de-extinction company Colossal Biosciences in Dallas, Texas — is an early technical success in Colossal’s high-profile effort to engineer elephants...
Mar 6, 2024 · De-extinction startup Colossal Biosciences claims it has found a way to reprogram elephant cells, a technical breakthrough that could lead to the return of the long-lost mammals.
